FDA Drug Recalls

Recalls / Class II

Class IID-0424-2015

Product

B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.

Affected lot / code info
Lot #: 20213, Exp 12/22/2016.

Why it was recalled

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Recalling firm

Firm
Bethel Nutritional Consulting, Inc
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
599 W 190th St Ste 1, New York, New York 10040-3577

Distribution

Quantity
UNKNOWN
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-12-19
FDA classified
2015-03-24
Posted by FDA
2015-04-01
Terminated
2018-06-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0424-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls